Prevention of chronic rejection with immunoregulatory cells induced by intrathymic immune modulation with class I allopeptides

American Journal of Transplantation

Volumn 3, Issue 5, 2003, Pages 581-589

  Shirwan, Haval ^a   Mhoyan, Anna ^a   Kakoulidis, Thanos P ^a   Yolcu, Esma S ^a   Ibrahim, Sherif ^b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b NEW YORK UNIVERSITY   (United States)

Author keywords

Cardiac allograft tolerance; Chronic rejection; Intrathymic immunomodulation; Regulatory cells

Indexed keywords

ALLOANTIGEN; PEPTIDE;

ADOPTIVE IMMUNOTHERAPY; ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; DRUG EFFECT; GRAFT SURVIVAL; HOST; HUMORAL IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOREGULATION; INCIDENCE; LYMPHOCYTE PROLIFERATION; NONHUMAN; ORGAN DONOR; RAT; RECIPIENT; SPLEEN CELL; T LYMPHOCYTE; WILD TYPE;

ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; ISOANTIGENS; PEPTIDES; RATS; RATS, INBRED F344; RATS, INBRED LEW; SPLEEN; T-LYMPHOCYTES; THYMUS GLAND; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0037908885     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2003.00052.x     Document Type: Article

References (45)

1. Braun MY, McCormack A, Webb G, Batchelor JR. Mediation of acute but not chronic rejection of MHC-incompatible rat kidney grafts by alloreactive CD4 T cells activated by the direct pathway of sensitization. Transplantation 1993; 55: 177-182.
2. bm3 molecule. J Immunol 1995; 155: 2419-2426.
3. Shirwan H, Barwari L, Cramer DV. Rejection of cardiac allografts by T cells expressing a restricted repertoire of T-cell receptor Vb genes. Immunology 1997; 90: 572-578.
4. Benichou G, Takizawa PA, Olson CA, McMillan M, Sercarz EE. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J Exp Med 1992; 175: 305-308.
5. Fangmann J, Dalchau R, Fabre JW. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. J Exp Med 1992; 175: 1521-1529.
6. + T cell and B cell responses after cardiac allografts rejection. Transplantation 1995; 59: 401-410.
7. Watschinger B, Gallon L, Carpenter CB, Sayegh MH. Mechanisms of allo-recognition: recognition by in vivo-primed T cells of specific major histocompatibility complex polymorphisms presented as peptides by responder antigen-presenting cells. Transplantation 1994; 57: 572-576.
8. Braun MY, McCormack A, Webb G, Batchelor JR. T cells mediating early acute kidney allograft rejection in the rat are different from those responsible for chronic rejection. Transplant Proc 1993; 25: 863-864.
9. Halloran PF, Broski AP, Batiuk TD, Madrenas J. The molecular immunology of acute rejection: an overview. Transplant Immunol 1993; 1: 3-27.
10. Shirwan H. Chronic allograft rejection. do the Th2 cells preferentially induced by indirect recognition play a dominant role? Transplantation 1999; 68: 715-726.
11. + T cell-dependent antibodymediated graft rejection. Immunol Today 1992; 13: 434-438.
12. Mhoyan A, Cramer DV, Baquerizo A, Shirwan H. Induction of allograft nonresponsiveness after intrathymic inoculation with donor class I allopeptides: 1. Correlation of graft survival with anti-donor IgG antibody subclasses. Transplantation 1997; 64: 1665-1670.
13. Shirwan H, Mhoyan A, Leamer M, Wang C, Cramer DV. The role of donor class I major histocompatibility complex peptides in the induction of allograft tolerance. Transplant Proc 1997; 29: 1134-1135.
14. Shirwan H, Wang C, Barwari L, Cramer DV. Recipient-donor microchimerism is not a prerequisite for the maintenance of allograft tolerance. Transplant Proc 1997; 29: 1182-1183.
15. Shirwan H, Barwari L, Sattar-Khan N. Predominant expression of Th2 and altered expression of Th1 cytokines in long-term allograft survival induced by intrathymic immune modulation with donor class I MHC peptides. Transplantation 1998; 66: 1802-1809.
16. Shirwan H, Wu GD, Barwari L, Liu A, Cramer DV. Induction of allograft nonresponsiveness after intrathymic inoculation with donor class I allopeptides. II. Evidence for persistent chronic rejection despite high levels of donor microchimerism. Transplantation 1997; 64: 1671-1676.
17. Sayegh MH, Perico N, Gallon L et al. Mechanisms of acquired thymic unresponsiveness to renal allografts: thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy. Transplantation 1994; 58: 125-132.
18. Odorico JS, Posselt AM, Naji A, Markmann JF, Barker CF. Promotion of rat cardiac allograft survival by intrathymic inoculation of donor splenocytes. Transplantation 1993; 55: 1104-1107.
19. Ohzato H, Monaco AP. Induction of specific unresponsiveness (tolerance) to skin allografts by intrathymic donor-specific splenocyte injection in antilymphocyte serum-treated mice. Transplantation 1992; 54: 1090-1095
20. Chen W, Sayegh MH, Khoury SJ. Mechanisms of acquired thymic tolerance in vivo: intrathymic injection of antigen induces apoptosis of thymocytes and peripheral T cell anergy. J Immunol 1998; 160: 1504-1508.
21. Oluwole SF, Jin MX, Chowdhury NC, Engelstad K, Ohajekwe OA, James T. Induction of peripheral tolerance by intrathymic inoculation of soluble alloantigens: evidence for the role of host antigen-presenting cells and suppressor cell mechanism. Cell Immunol 1995; 162: 33-41.
22. Binder J, Graser E, Hancock WW et al. Downregulation of intragraft IFN-gamma expression correlates with increased IgG1 alloantibody response following intrathymic immunomodulation of sensitized rat recipients. Transplantation 1995; 60: 1516-1524.
23. Cramer DV, Shirwan H. The importance of humoral immune responses in chronic rejection. Transplant Rev 1998; 12: 166-176.
24. Hancock WW, Buelow R, Sayegh MH, Turka LA. Antibody-induced transplant arteriosclerosis is prevented by graft expression of antioxidant and anti-apoptotic genes. Nat Med 1998; 4: 1392-1396.
25. Furukawa Y, Becker G, Stinn JL, Shimizu K, Libby P, Mitchell RN. Interleukin-10 (IL-10) augments allograft arterial disease: paradoxical effects of IL-10 in vivo. Am J Pathol 1999; 155: 1929-1939.
26. Zhang X, Izikson L, Liu L, Weiner HL. Activation of CD25 (+) CD4 (+) regulatory T cells by oral antigen administration. J Immunol 2001; 167: 4245-4253.
27. Itoh M, Takahashi T, Sakaguchi N et al. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 1999; 162: 5317-5326.
28. Sakaguchi S, Sakaguchi N, Shimizu J et al. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001; 182: 18-32.
29. Qin S, Cobbold SP, Pope H et al. 'Infectious' transplantation tolerance. Science 1993; 259: 974-977.
30. Yin D, Fathman CG. CD4-positive suppressor cells block allotransplant rejection. J Immunol 1995; 154: 6339-6345.
31. Saborio DV, Chowdhury NC, Jin MX, Chandraker A, Sayegh MH, Oluwole SF. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides. Cell Transplant 1999; 8: 375-381.
32. Adams DH, Tilney NL, Collins JJJ, Karnovsky MJ. Experimental graft arteriosclerosis. I. The Lewis-to-F-344 allograft model. Transplantation 1992; 53: 1115-1119.
33. Reemtsen BL, Kato H, Wang TS, Busuttil RW, Kupiec-Weglinski JW, Goss JA. Intrathymic immunomodulation and the 'infectious' tolerance pathway in allograft recipients. J Surg Res 1999; 84: 1-7.
34. Goss JA, Nakafusa Y, Roland CR, Hickey WF, Flye MW. Immunological tolerance to a defined myelin basic protein antigen administered intrathymically. J Immunol 1994; 153: 3890-3898.
35. Markmann JF, Bassiri H, Desai NM, Kim JI, Odorico JS, Barker CF. Donor antigen-specific T lymphocyte deletion after intrathymic inoculation. Transplant Proc 1993; 25: 305-306.
36. Chowdhury NC, Murphy B, Sayegh MH et al. Acquired systemic tolerance to rat cardiac allografts induced by intrathymic inoculation of synthetic polymorphic MHC class I allopeptides. Transplantation 1996; 62: 1878-1882.
37. Sayegh MH, Perico N, Imberti O, Hancock WW, Carpenter CB, Remuzzi G. Thymic recognition of class II major histocompatibility complex allopeptides induces donor-specific unresponsiveness to renal allografts. Transplantation 1993; 56: 461-465.
38. Hillebrands JL, Raue HP, Klatter FA et al. Intrathymic immune modulation prevents acute rejection but not the development of graft arteriosclerosis (chronic rejection). Transplantation 2001; 71: 914-924.
39. Goss JA, Nakafusa YYuS, Flye MW. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts. Transplantation 1993; 56: 166-173.
40. Oluwole SF, Chowdhury NC, Fawwaz RA. Induction of donorspecific unresponsiveness to rat cardiac allografts by intrathymic injection of UV-B-irradiated donor spleen cells. Transplantation 1993; 55: 1389-1395.
41. Lombardi G, Sidhu S, Batchelor R, Lechler R. Anergic T cells as suppressor cells in vitro. Science 1994; 264: 1587-1589.
42. Khoury SJ, Gallon L, Chen W et al. Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: Thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo. J Exp Med 1995; 182: 357-366.
43. Oluwole OO, DePaz HA, Gopinathan R et al. Indirect allorecognition in acquired thymic tolerance: induction of donor-specific permanent acceptance of rat islets by adoptive transfer of allopeptide-pulsed host myeloid and thymic dendritic cells. Diabetes 2001; 50: 1546-1552.
44. Agus DB, Surh CD, Sprent J. Re-entry of T cells to the adult thymus is restricted to activated T cells. J Exp Med 1991; 173: 1039-1046.
45. Davies JD, Leong LYW, Mellor A, Cobbold S, Waldmann H. T cell suppression in transplantation tolerance through linked recognition. J Immunol 1996; 156: 3602-3607.